wanyu/IteraTeR_v2 huggingface dataset:
Original:  The sun was shining (it was the third of August) and the little salt prisms glittered like the finest diamonds in a brightly lit ballroom.
Revised:  The sun was shining and the salt prisms glittered like the finest diamonds in a brightly lit ballroom.
Edit intent: coherence
Original:  Not all selection biases can be explained by physical saliency ( top down ) or observer goals ( bottom up ).
Revised:  Not all selection biases can be explained by physical saliency ( bottom up ) or observer goals ( bottom up ).
Edit intent: fluency
Original:  Not all selection biases can be explained by physical saliency ( top down ) or observer goals ( bottom up ).
Revised:  Not all selection biases can be explained by physical saliency ( top down ) or observer goals ( top down ).
Edit intent: fluency
Original: Priming of Pop-out hypothesis The Priming of Pop-out hypothesis suggests performance in a visual search task involving a pop-out target can be affected by the search history of specific target features in previous trials.
Revised: Priming of pop-out hypothesis The priming of pop-out hypothesis suggests performance in a visual search task involving a pop-out target can be affected by the search history of specific target features in previous trials.
Edit intent: fluency
Original:  The hypothesis proposes the repetition of a target used in a preceding trial makes it’s pop-out features more salient to an observer and therefore increases the likelihood the observer will attend to it.
Revised:  The hypothesis proposes the repetition of a target used in a preceding trial makes its pop-out features more salient to an observer and therefore increases the likelihood the observer will attend to it.
Edit intent: fluency
Original: Why intertrial priming occurs (major theories) Dimension-Weighting Account theory The " Dimension-Weighting Account " of visual selection states that there is a limit to the attentional weight that can be allocated to a particular dimension of an object at any one time.
Revised: Why it occurs (major theories) Dimension-Weighting Account theory The " Dimension-Weighting Account " of visual selection states that there is a limit to the attentional weight that can be allocated to a particular dimension of an object at any one time.
Edit intent: clarity
Original: Why intertrial priming occurs (major theories) Dimension-Weighting Account theory The " Dimension-Weighting Account " of visual selection states that there is a limit to the attentional weight that can be allocated to a particular dimension of an object at any one time.
Revised: Why intertrial priming occurs (major theories) Dimension-weighting account theory The " Dimension-Weighting Account " of visual selection states that there is a limit to the attentional weight that can be allocated to a particular dimension of an object at any one time.
Edit intent: fluency
Original: Why intertrial priming occurs (major theories) Dimension-Weighting Account theory The " Dimension-Weighting Account " of visual selection states that there is a limit to the attentional weight that can be allocated to a particular dimension of an object at any one time.
Revised: Why intertrial priming occurs (major theories) Dimension-Weighting Account theory The " dimension-weighting account " of visual selection states that there is a limit to the attentional weight that can be allocated to a particular dimension of an object at any one time.
Edit intent: fluency
Original:  Episodic Retrieval hypothesis The Episodic Retrieval model suggests reduced response times in intertrial priming are due to the observers' retrieval of episodic memories relevant to the task.
Revised:  Episodic retrieval hypothesis The episodic retrieval model suggests reduced response times in intertrial priming are due to the observers' retrieval of episodic memories relevant to the task.
Edit intent: fluency
Original: Measures of Visual Spatial Attention Spatial Cueing Experiments A key property of visual attention is that attention can be selected based on spatial location and spatial cueing experiments have been used to assess this type of selection.
Revised: Measures of visual spatial attention Spatial Cueing Experiments A key property of visual attention is that attention can be selected based on spatial location and spatial cueing experiments have been used to assess this type of selection.
Edit intent: fluency
Original: Measures of Visual Spatial Attention Spatial Cueing Experiments A key property of visual attention is that attention can be selected based on spatial location and spatial cueing experiments have been used to assess this type of selection.
Revised: Measures of Visual Spatial Attention Spatial cueing experiments A key property of visual attention is that attention can be selected based on spatial location and spatial cueing experiments have been used to assess this type of selection.
Edit intent: fluency
Original:  Spatial Probe Experiments In spatial cueing tasks, the spatial probe (cue) causes an allocation of attention to a particular location.
Revised:  Spatial probe experiments In spatial cueing tasks, the spatial probe (cue) causes an allocation of attention to a particular location.
Edit intent: fluency
Original:  Distribution of Spatial Attention The distribution of spatial attention has been subject to considerable research.
Revised:  Distribution of spatial attention The distribution of spatial attention has been subject to considerable research.
Edit intent: fluency
Original:  Spotlight Metaphor According to the ‘spotlight’ metaphor, the focus of attention is analogous to the beam of a spotlight.
Revised:  Spotlight metaphor According to the ‘spotlight’ metaphor, the focus of attention is analogous to the beam of a spotlight.
Edit intent: clarity
Original:  Zoom-Lens Metaphor Research has suggested that the attentional focus is variable in size.
Revised:  Zoom-lens metaphor Research has suggested that the attentional focus is variable in size.
Edit intent: fluency
Original:  Gradient Model The Gradient Model is an alternative theory on the distribution of spatial attention.
Revised:  Gradient model The Gradient Model is an alternative theory on the distribution of spatial attention.
Edit intent: fluency
Original:  Splitting Spatial Attention It is debated in research on visual spatial attention whether it is possible to split attention across different areas in the visual field.
Revised:  Splitting spatial attention It is debated in research on visual spatial attention whether it is possible to split attention across different areas in the visual field.
Edit intent: fluency
Original:  Deficits in Visual Spatial Attention Regions Associated with Impairment of Visuospatial Attention Parietal Damage The posterior parietal region is arguably the most extensively studied in relation to visuospatial attention.
Revised:  Deficits in visual spatial attention Regions Associated with Impairment of Visuospatial Attention Parietal Damage The posterior parietal region is arguably the most extensively studied in relation to visuospatial attention.
Edit intent: fluency
Original:  Deficits in Visual Spatial Attention Regions Associated with Impairment of Visuospatial Attention Parietal Damage The posterior parietal region is arguably the most extensively studied in relation to visuospatial attention.
Revised:  Deficits in Visual Spatial Attention Regions associated with impairment of visuospatial attention Parietal Damage The posterior parietal region is arguably the most extensively studied in relation to visuospatial attention.
Edit intent: fluency
Original:  Deficits in Visual Spatial Attention Regions Associated with Impairment of Visuospatial Attention Parietal Damage The posterior parietal region is arguably the most extensively studied in relation to visuospatial attention.
Revised:  Deficits in Visual Spatial Attention Regions Associated with Impairment of Visuospatial Attention Parietal damage The posterior parietal region is arguably the most extensively studied in relation to visuospatial attention.
Edit intent: fluency
Original:  Frontal Lobe Damage Lesions to the frontal cortices have long been known to precede spatial neglect and other visuospatial deficits.
Revised:  Frontal lobe damage Lesions to the frontal cortices have long been known to precede spatial neglect and other visuospatial deficits.
Edit intent: fluency
Original:  Thalamic Nuclei Damage (Pulvinar Nucleus ) The thalamic nuclei have been speculated to be involved in directing attention to locations in visual space.
Revised:  Thalamic nuclei damage (pulvinar nucleus ) The thalamic nuclei have been speculated to be involved in directing attention to locations in visual space.
Edit intent: fluency
Original:  See also  Attention Visual temporal attention Action Recognition
Revised:  See also Activity recognition / action recognition Attention Visual temporal attention Action Recognition
Edit intent: clarity
Original:  Attention is guided even more quickly to unexpected locations, when these locations are made salient by external visual inputs (such as a sudden flash), the human primary visual cortex plays a critical role for such  exogenous attentional guidance Li. Z. 2002 A saliency map in primary visual cortex Trends in Cognitive Sciences vol.
Revised:  Attention is guided even more quickly to unexpected locations, when these locations are made salient by external visual inputs (such as a sudden flash), the human primary visual cortex plays a critical role for such an exogenous attentional guidance Li. Z. 2002 A saliency map in primary visual cortex Trends in Cognitive Sciences vol.
Edit intent: fluency
Original: Difficulty of compliance Due to the nature of restricted distribution programs in general, and ETASU REMS programs specifically, stakeholder burden has always been balanced against control and compliance.
Revised: Difficulty of compliance 
Edit intent: coherence
Original:  The program has not reduced exposure of pregnant women to the drug, and has also been criticized for being overly complicated . iPLEDGE users have no platform to speak out about their frustrations.
Revised:  The program has reduced exposure of pregnant women to the drug, and has also been criticized for being overly complicated . iPLEDGE users have no platform to speak out about their frustrations.
Edit intent: coherence
Original: The iPLEDGE program is a risk management distribution program mandated by the U.S. Food and Drug Administration (FDA) for isotretinoin, marketed as Absorica, Claravis, Amnesteem, Myorisan, and Zenatane, and sometimes referred to by its former brand name, Accutane.
Revised: The iPLEDGE program is a program by the U.S. Food and Drug Administration (FDA) for isotretinoin, marketed as Absorica, Claravis, Amnesteem, Myorisan, and Zenatane, and sometimes referred to by its former brand name, Accutane.
Edit intent: clarity
Original:  Isotretinoin is a prescription medication that is highly effective in treating severe acneand moderate acne that doesn't respond to other treatments, however  carries a high risk of causing severe birth defects if taken during pregnancy (see Teratogenicity of isoretinoin) .
Revised:  Isotretinoin is a prescription medication that is highly effective in treating severe acneand moderate acne that doesn't respond to other treatments, however Isotretinoin carries a high risk of causing severe birth defects if taken during pregnancy (see Teratogenicity of isoretinoin) .
Edit intent: fluency
Original:  The goals of the iPLEDGE REMS (risk evaluation and mitigation strategy) Program are to prevent fetal exposure to isotretinoin and to inform prescribers, pharmacists, and patients about isotretinoin's serious risks and safe-use conditions.
Revised:  The goals of the iPLEDGE REMS (risk evaluation and mitigation strategy) program are to prevent fetal exposure to isotretinoin and to inform prescribers, pharmacists, and patients about isotretinoin's serious risks and safe-use conditions.
Edit intent: fluency
Original:  The program was designed by the Isotretinoin Product Manufacturers Group (IPMG) and its chosen vendor, Covance, under the direction of the FDA . As of March 1, 2006, iPLEDGE patients, their doctors and their pharmacists are required by the FDA to register and use a web site in order to receive, prescribe or dispense this medication.
Revised:  The program was designed by the Isotretinoin Product Manufacturers Group (IPMG) and its chosen vendor, Covance, under the direction of the FDA As of March 1, 2006, iPLEDGE patients, their doctors and their pharmacists are required by the FDA to register and use a web site in order to receive, prescribe or dispense this medication.
Edit intent: fluency
Original:  The program was designed by the Isotretinoin Product Manufacturers Group (IPMG) and its chosen vendor, Covance, under the direction of the FDA . As of March 1, 2006, iPLEDGE patients, their doctors and their pharmacists are required by the FDA to register and use a web site in order to receive, prescribe or dispense this medication.
Revised:  The program was designed by the Isotretinoin Product Manufacturers Group (IPMG) and its chosen vendor, Covance, under the direction of the FDA . As of March 1, 2006.
Edit intent: coherence
Original:  Patients who acquire and consume isotretinoin without the care of a prescriber are putting themselves in jeopardy.
Edit intent: clarity
Original: Process Once a doctor decides a patient is a candidate for isotretinoin, they will counsel the patient to ensure the patient understands the drug and the potential side effects.
Revised: Process Once a doctor decides a patient is a candidate for isotretinoin, they will counsel the patient to ensure they understand the drug and the potential side effects.
Edit intent: clarity
Original:  Once the patient signs the necessary paperwork, their doctor will give them a patient ID number and ID card, as well as other program educational materials.
Revised:  Once the patient signs the necessary paperwork, their doctor will give them a patient ID number , ID card, as well as other program educational materials.
Edit intent: coherence
Original:  Once the patient signs the necessary paperwork, their doctor will give them a patient ID number and ID card, as well as other program educational materials.
Revised:  Once the patient signs the necessary paperwork, their doctor will give them a patient ID number and ID card, and program educational materials.
Edit intent: clarity
Original:  After they have been registered in iPLEDGE by their doctor, they will receive their password in the mail after 5–10 business days.
Revised:  After a patient has been registered in iPLEDGE by their doctor, they will receive their password in the mail after 5–10 business days.
Edit intent: clarity
Original:  After they have been registered in iPLEDGE by their doctor, they will receive their password in the mail after 5–10 business days.
Revised:  After they have been registered in iPLEDGE by their doctor, they receive their password in the mail after 5–10 business days.
Edit intent: clarity
Original:  After they have been registered in iPLEDGE by their doctor, they will receive their password in the mail after 5–10 business days.
Revised:  After they have been registered in iPLEDGE by their doctor, they will receive their password in the mail within 5–10 business days.
Edit intent: clarity
Original:   FCBPs are required to pick and use two birth control methods (abstinence included), and must take doctor-administered pregnancy tests in two consecutive months.
Revised:  Patients who can get pregnant are required to pick and use two birth control methods (abstinence included), and must take doctor-administered pregnancy tests in two consecutive months.
Edit intent: clarity
Original:  After the second (confirmatory) negative pregnancy test, the FCBP must also take an online comprehension test to ensure she understands the requirements of the Program.
Revised:  After the second (confirmatory) negative pregnancy test, the patient must also take an online comprehension test to ensure she understands the requirements of the Program.
Edit intent: clarity
Original:  After the second (confirmatory) negative pregnancy test, the FCBP must also take an online comprehension test to ensure she understands the requirements of the Program.
Revised:  After the second (confirmatory) negative pregnancy test, the FCBP must also take an online comprehension test to ensure they understand the requirements of the Program.
Edit intent: clarity
Original:  Males and FnCBPs must see their doctor every month, but don't have to take the pregnancy or comprehension tests.
Revised:  Patients who cannot get pregnant must see their doctor every month, but don't have to take the pregnancy or comprehension tests.
Edit intent: clarity
Original:  Instituted in April 2002, SMART aimed to eliminate isotretinoin-induced birth defects by preventing pregnant women from being prescribed or exposed to the drug  .
Revised:  Instituted in April 2002, SMART aimed to eliminate isotretinoin-induced birth defects by preventing exposure to the drug .
Edit intent: clarity
Original:  Instituted in April 2002, SMART aimed to eliminate isotretinoin-induced birth defects by preventing pregnant women from being prescribed or exposed to the drug  .
Revised:  Instituted in April 2002, SMART aimed to eliminate isotretinoin-induced birth defects by preventing pregnant women from being prescribed or exposed to the drug during pregnancy .
Edit intent: clarity
Original:  However, no effort was made to verify the compliance of doctors and pharmacists, only a small percentage of women registered in the survey, and isotretinoin's reputation as an acne wonder drug continued to fuel demand for new prescriptions, an increasing number of which were being written and dispensed for relatively minor cases of acne vulgaris without proper screening, supervision or evidence that less risky medications had first been attempted.
Revised:  However, no effort was made to verify the compliance of doctors and pharmacists, only a small percentage of people registered in the survey, and isotretinoin's reputation as an acne wonder drug continued to fuel demand for new prescriptions, an increasing number of which were being written and dispensed for relatively minor cases of acne vulgaris without proper screening, supervision or evidence that less risky medications had first been attempted.
Edit intent: clarity
Original:  Failure of the previous system In 2003, a first-year review of SMART compliance conducted by the pharmaceutical industry revealed that the number of pregnant women prescribed isotretinoin actually increased by hundreds of documented cases over the previous year, before the program was instituted.
Revised:  Failure of the previous system In 2003, a first-year review of SMART compliance conducted by the pharmaceutical industry revealed that the number of pregnant people prescribed isotretinoin actually increased by hundreds of documented cases over the previous year, before the program was instituted.
Edit intent: clarity
Original:  Of these cases, the majority of women underwent abortions—either spontaneous or elective—with a handful of children reported to be born with typical isotretinoin-induced birth defects.
Revised:  Of these cases, the majority underwent abortions—either spontaneous or elective—with a handful of children reported to be born with typical isotretinoin-induced birth defects.
Edit intent: clarity
Original:  When surveyed, many pregnant women reported that their physicians had attempted to downplay the risks of isotretinoin or violated the standards in other ways, such as failing to inform women they needed to use two forms of birth control or allowing them to substitute a single, less-accurate urine pregnancy test conducted in the doctor's office for the two laboratory-conducted blood pregnancy tests mandated by SMART.
Revised:  When surveyed, many pregnant people reported that their physicians had attempted to downplay the risks of isotretinoin or violated the standards in other ways, such as failing to inform women they needed to use two forms of birth control or allowing them to substitute a single, less-accurate urine pregnancy test conducted in the doctor's office for the two laboratory-conducted blood pregnancy tests mandated by SMART.
Edit intent: clarity
Original:  When surveyed, many pregnant women reported that their physicians had attempted to downplay the risks of isotretinoin or violated the standards in other ways, such as failing to inform women they needed to use two forms of birth control or allowing them to substitute a single, less-accurate urine pregnancy test conducted in the doctor's office for the two laboratory-conducted blood pregnancy tests mandated by SMART.
Revised:  When surveyed, many pregnant women reported that their physicians had attempted to downplay the risks of isotretinoin or violated the standards in other ways, such as failing to inform them of the need to use two forms of birth control or allowing them to substitute a single, less-accurate urine pregnancy test conducted in the doctor's office for the two laboratory-conducted blood pregnancy tests mandated by SMART.
Edit intent: clarity
Original:  Women Still Having Risky Pregnancies While Taking Accutane", Feb 27, 2004 Mandatory reporting and verification The report led to SMART being dismissed as "a total failure", with the FDA quickly moving to halt the downward slide with a stricter mandatory registry system to document and verify all isotretinoin prescriptions written or dispensed to childbearing-age women in the United States.
Revised:  Women Still Having Risky Pregnancies While Taking Accutane", Feb 27, 2004 Mandatory reporting and verification The report led to SMART being dismissed as "a total failure", with the FDA quickly moving to halt the downward slide with a stricter mandatory registry system to document and verify all isotretinoin prescriptions written or dispensed in the United States.
Edit intent: clarity
Original:  In the U.S., around 2000 women became pregnant while taking the drug between 1982 and 2000, with most pregnancies ending in abortion or miscarriage.
Revised:  In the U.S., around 2000 people became pregnant while taking the drug between 1982 and 2000, with most pregnancies ending in abortion or miscarriage.
Edit intent: clarity
Original:  After the FDA put the more strict iPLEDGE program in place for the companies marketing the drug in the US, in 2011 , 155 pregnancies occurred among 129,544 women of childbearing potential taking isotrentinoin (0.12\%)  .
Revised:  In 2011, after the FDA put the more strict iPLEDGE program in place for the companies marketing the drug in the US, in 2011 , 155 pregnancies occurred among 129,544 women of childbearing potential taking isotrentinoin (0.12\%) .
Edit intent: coherence
Original:  After the FDA put the more strict iPLEDGE program in place for the companies marketing the drug in the US, in 2011 , 155 pregnancies occurred among 129,544 women of childbearing potential taking isotrentinoin (0.12\%)  .
Revised:  After the FDA put the more strict iPLEDGE program in place , 155 pregnancies occurred among 129,544 women of childbearing potential taking isotrentinoin (0.12\%) .
Edit intent: clarity
Original:  Additionally, maintenance of a pregnancy registry is part of the Program, though participation in the registry is voluntary for those patients who might 've become pregnant.
Revised:  Additionally, maintenance of a pregnancy registry is part of the Program, though participation in the registry is voluntary for those patients who might have become pregnant.
Edit intent: fluency